Related references
Note: Only part of the references are listed.Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies
Meng-Zhu Shen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis
Joseph E. Maakaron et al.
BONE MARROW TRANSPLANTATION (2022)
Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia
Servais Sophie et al.
STEM CELLS TRANSLATIONAL MEDICINE (2022)
Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients
Ying Zhao et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies improved outcomes over two decades
Jason P. Cooper et al.
HAEMATOLOGICA (2021)
Venetoclax and donor lymphocyte infusion for early relapsed acute myeloid leukemia after allogeneic hematopoietic cell transplantation. A retrospective multicenter trial
Odelia Amit et al.
ANNALS OF HEMATOLOGY (2021)
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant
Premal D. Lulla et al.
BLOOD (2021)
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia
Charles Craddock et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation
Marco Pellegrini et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
Jing-Rui Zhou et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry
Roni Shouval et al.
Lancet Haematology (2021)
Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim
Sherman Chu et al.
CLINICAL IMMUNOLOGY (2021)
Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
Tor Henrik Anderson Tvedt et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Changing Epidemiology of Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplantation
Pedro Puerta-Alcalde et al.
JOURNAL OF FUNGI (2021)
Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects
Lam T. Khuat et al.
BLOOD (2021)
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Increased Incidence of Human Papillomavirus-Related Precancer or Second Malignancy Among Allogeneic Stem Cell Transplantation Patients: A SEER-Medicare Population Study
Hui Zhao et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide
Patrice Chevallier et al.
ACTA ONCOLOGICA (2021)
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation
Ajit P. Limaye et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study
Daniel A. Pollyea et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease
Juan Montoro et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
Stefan O. Ciurea et al.
BLOOD (2020)
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel
Francesca Bonifazi et al.
BONE MARROW TRANSPLANTATION (2020)
A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China
Chun-Li Zhang et al.
CHINESE MEDICAL JOURNAL (2020)
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
Ahmad I. Antar et al.
LEUKEMIA (2020)
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Ali Bazarbachi et al.
HAEMATOLOGICA (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation
Regis Peffault De Latour et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation
Burak Kalin et al.
BLOOD ADVANCES (2020)
Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial
Lei Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
Misti Ellsworth et al.
JOURNAL OF FUNGI (2020)
Impact of Age on the Outcomes of HCT for AML in CR1: Promising Therapy for Older Adults
Joseph Maakaron et al.
BLOOD (2020)
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report
Zheng Zhou et al.
BLOOD ADVANCES (2020)
Cardiac Complications in the Adult Bone Marrow Transplant Patient
Mirela Tuzovic et al.
CURRENT ONCOLOGY REPORTS (2019)
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
Javier Bolanos-Meade et al.
LANCET HAEMATOLOGY (2019)
Late Complications of Allogenic Stem Cells Transplantation in Leukaemia
Sharmilla Kanagasundram et al.
TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2019)
Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective study
Ron Ram et al.
ANNALS OF HEMATOLOGY (2019)
Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
Eva Karam et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients
Andrea Bacigalupo et al.
BONE MARROW TRANSPLANTATION (2019)
Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation
Katherine N. Ward et al.
HAEMATOLOGICA (2019)
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
Brenda M. Sandmaier et al.
LANCET HAEMATOLOGY (2019)
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia
Lauren VeltriVeltri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment
Christina Rautenberg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Variability of performance status assessment between patients with hematologic malignancies and their physicians
Alexis D. Leal et al.
LEUKEMIA & LYMPHOMA (2018)
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
Marcos de Lima et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation
Zinaida Peric et al.
BONE MARROW TRANSPLANTATION (2018)
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
Courtney L. DiNardo et al.
LANCET ONCOLOGY (2018)
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
Mohamed A. Kharfan-Dabaja et al.
JAMA ONCOLOGY (2018)
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
M. J. Christopher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia
Jun Yang et al.
ANNALS OF HEMATOLOGY (2018)
Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study
Sun Bean Kim et al.
MEDICAL MYCOLOGY (2017)
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Romuald Bellmann et al.
INFECTION (2017)
A review of infectious complications after haploidentical hematopoietic stem cell transplantations
Erden Atilla et al.
INFECTION (2017)
Haploidentical Hematopoietic Cell Transplant with Post Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome
Michael Slade et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial
Jan Moritz Middeke et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stern Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia
Chen-Hua Yan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Cytogenetic Risk Determines Outcomes After Allogeneic Transplantation in Older Patients With Acute Myeloid Leukemia in Their Second Complete Remission: A Center for International Blood and Marrow Transplant Research Cohort Analysis
Fotios V. Michelis et al.
CANCER (2017)
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
Yvette L. Kasamon et al.
BLOOD ADVANCES (2017)
Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Florent Malard et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Selecting initial treatment of acute myeloid leukaemia in older adults
Nikolai A. Podoltsev et al.
BLOOD REVIEWS (2017)
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
Craig Kollman et al.
BLOOD (2016)
Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012
A. G. Dinmohamed et al.
LEUKEMIA (2016)
Modern approaches to HLA-haploidentical blood or marrow transplantation
Christopher G. Kanakry et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi
Amit Desai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Outcomes of Allogeneic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-analysis
Armin Rashidi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated
Ramzi Abboud et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (≥60 years)
M. Pohlen et al.
BONE MARROW TRANSPLANTATION (2016)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation
Jun Fan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia
Sijian Yu et al.
MEDICINE (2016)
Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: What we do and do not know
M. Ogata et al.
BONE MARROW TRANSPLANTATION (2015)
Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia
Ji Eun Jang et al.
ANNALS OF HEMATOLOGY (2015)
How we treat chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2015)
Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Frederic Baron et al.
CANCER (2015)
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italian Trapianto Midollo Osseo (GITMO)
Corrado Girmenia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide
Luca Castagna et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years with Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant
Fotios V. Michelis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT
Yi Luo et al.
BLOOD (2014)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
N. Lerolle et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Molecular and Nonmolecular Diagnostic Methods for Invasive Fungal Infections
Marios Arvanitis et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Pilot Study of Comprehensive Geriatric Assessment (CGA) in Allogeneic Transplant: CGA Captures a High Prevalence of Vulnerabilities in Older Transplant Recipients
Lori S. Muffly et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
Heidi D. Klepin et al.
BLOOD (2013)
Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR
F. V. Michelis et al.
BONE MARROW TRANSPLANTATION (2013)
Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes
Alexander E. Sherman et al.
LEUKEMIA RESEARCH (2013)
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2012)
Acute myeloid leukemia in the real world: why population-based registries are needed
Gunnar Juliusson et al.
BLOOD (2012)
Survival for older patients with acute myeloid leukemia: a population-based study
Betul Oran et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience
Zdenek Racil et al.
MYCOSES (2012)
Transplantation in the onco-hematology field: Focus on the manipulation of αβ and γδ T cells
Nicola Daniele et al.
PATHOLOGY RESEARCH AND PRACTICE (2012)
Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison
Yu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303
Steven M. Devine et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT
K. Ishiyama et al.
BONE MARROW TRANSPLANTATION (2011)
The Treatment of Chronic Graft-Versus-Host Disease
Daniel Wolff et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2011)
A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants
Philipp G. Hemmati et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor
Alicia Rovo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age
Emilie Castermans et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia
Heidi D. Klepin et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
Yvette L. Kasamon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation
V. R. Shannon et al.
BONE MARROW TRANSPLANTATION (2010)
Quantifying the Survival Benefit for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Acute Myelogenous Leukemia
Paul M. Armistead et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Predictors of Avascular Necrosis of Bone in Long-Term Survivors of Hematopoietic Cell Transplantation
Stephanie Campbell et al.
CANCER (2009)
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
P. Ljungman et al.
BONE MARROW TRANSPLANTATION (2008)
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation:: Chronic graft-versus-host disease is the strongest factor improving survival
David Valcarel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy
S. Yao et al.
BONE MARROW TRANSPLANTATION (2008)
Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation
M. Ogata et al.
BONE MARROW TRANSPLANTATION (2008)
Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions
Xiao-Jun Huang et al.
TRANSPLANT IMMUNOLOGY (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6
AP Smith et al.
JOURNAL OF VIROLOGY (2005)
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
M Maris et al.
EXPERIMENTAL HEMATOLOGY (2003)
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
KA Marr et al.
BLOOD (2002)
Share Paper
